{
    "Title": "Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)",
    "URL": "https://doi.org/10.1371/journal.pntd.0008644",
    "Published": "October 12, 2020",
    "Subject_Areas": [
        "Lymphatic filariasis",
        "Medical risk factors",
        "Drug administration",
        "Infectious disease control",
        "Nematode infections",
        "Parasitic diseases",
        "Public and occupational health",
        "Adults"
    ],
    "Authors": {
        "Benjamin S. Collyer": [
            "Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, St Mary\u2019s Campus, Imperial College London, London, United Kingdom"
        ],
        "Michael A. Irvine": [
            "Institute of Applied Mathematics, University of British Columbia, Vancouver, Canada"
        ],
        "T. Deidre Hollingsworth": [
            "Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom"
        ],
        "Mark Bradley": [
            "Global Health Program, GlaxoSmithKline (GSK), Brentford, United Kingdom"
        ],
        "Roy M. Anderson": [
            "Department of Infectious Disease Epidemiology, School of Public Health, Faculty of Medicine, St Mary\u2019s Campus, Imperial College London, London, United Kingdom"
        ]
    }
}